FiercePharmaAsia—Sinopharm, Sinovac COVID vaccines; Takeda’s warning letter, $2B pipeline cull

Meanwhile, Takeda is transferring several neuroscience programs to Neurocrine Biosciences. For the seven assets, including clinical-stage drugs in …

Link to Full Article: Read Here